Tenet Healthcare (THC) Tops Q4 EPS by 1c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus, Provides FY20 EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. SPCX
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to Tenet Healthcare (THC) Tops Q4 EPS by 1c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus, Provides FY20 EPS Outlook

Tenet Reports Results for the Fourth Quarter and Year Ended December 31, 2019 and Issues Financial Outlook for 2020

February 24, 2020 4:21 PM EST

Net income from continuing operations attributable to common shareholders of $2 million, or $0.02 per diluted share, in 4Q19 versus a net loss from continuing operations of $5 million, or $0.05 per diluted share in 4Q18 Several 4Q19 key financial metrics up significantly year over year: Consolidated Adjusted EBITDA up 18 percent (above the Outlook mid-point) Consolidated Adjusted diluted EPS up 94 percent (above the Outlook mid-point) Hospital segment Adjusted EBITDA up 16 percent Ambulatory segment EBITDA less NCI up 26 percent Conifer segment Adjusted EBITDA up 8 percent; related... More